Releases Saturday 16 June 2001
No 7300 Volume 322

Please remember to credit the BMJ as source when publicising an
article and to tell your readers that they can read its full text on the
journal's web site (http://bmj.com).

If your story is posted on a website please include a link back to
the source BMJ article (URL's are given under titles).



(1)  HIGH BLOOD PRESSURE AND CHOLESTEROL
LEVELS INCREASE RISK OF ALZHEIMER'S

(2)  STRATEGIES TO CUT RISKY SEXUAL
BEHAVIOUR MAY DO MORE HARM THAN
GOOD
 


 

(1)  HIGH BLOOD PRESSURE AND CHOLESTEROL
LEVELS INCREASE RISK OF ALZHEIMER'S

(Midlife vascular risk factors and Alzheimer's disease in
later life: longitudinal, population based study)
http://bmj.com/cgi/content/full/322/7300/1447

A combination of raised blood pressure and high
cholesterol levels in midlife, greatly increases the risk of
Alzheimer's disease in later life, finds a study in this week's
BMJ. These findings suggest that more emphasis should
be placed on identification and appropriate treatment of
these conditions.

A total of 1449 people who took part in a study during
the 1970s and 1980s were re-examined in 1998, aged
65-79. This included a questionnaire on medical history
and cerebrovascular and cardiovascular events and
vascular conditions diagnosed by a physician. Height,
weight and blood pressure were measured and blood
specimens were taken to determine cholesterol levels.

People with raised systolic blood pressure or high
cholesterol levels in midlife had a significantly higher risk of
Alzheimer's disease in later life than those with normal
blood pressure or cholesterol levels, even after factors
including age, education, smoking status and alcohol
consumption were taken into account. Participants with
both of these risk factors in midlife were at an even greater
risk of developing Alzheimer's disease than those with
either of these risk factors alone.

Given that both raised blood pressure and high cholesterol
levels can be treated, these results may have important
implications for the prevention of dementia, conclude the
authors.

Contact:

Miia Kivipelto, Research Fellow, Department of
Neuroscience and Neurology, University of Kuopio,
Finland
Email:  miia.kivipelto{at}uku.fi
 

(2)  STRATEGIES TO CUT RISKY SEXUAL
BEHAVIOUR MAY DO MORE HARM THAN
GOOD

(A cognitive behavioural intervention to reduce sexually
transmitted infections among gay men: randomised trial)
http://bmj.com/cgi/content/full/322/7300/1451

Strategies aimed at changing sexual behaviour to prevent
the transmission of HIV should not be assumed to bring
benefit and potentially may even do more harm than good,
finds a study in this week's BMJ. More rigorous
evaluation of such interventions is needed, report the
authors.

To determine the effectiveness of a brief behavioural
intervention in reducing sexual risk behaviour among gay
men, researchers at a sexual health clinic in London
recruited 343 gay men with an acute sexually transmitted
infection or who reported having had unprotected anal
intercourse in the past year.

All men received standard management consisting of a
brief (20 minute) one to one counselling session about
sexual risk behaviour. Additionally, a randomly selected
group of 175 men were invited to a one day workshop
(intervention group). For the following 12 months, the
number of new infections diagnosed at the clinic were
recorded and self-reported changes in sexual behaviour
were assessed using postal questionnaires.

Although this intervention was acceptable and feasible to
use in a busy clinic, it failed to reduce the risk of these men
acquiring new infections. In fact, a larger proportion of the
intervention group (31%) had at least one new sexually
transmitted infection diagnosed at the clinic compared with
the control group (21%) during the 12 month follow up.

The higher risk of acquiring a sexually transmitted infection
among men in the intervention group was unexpected, and
clearly a cause for concern, say the authors. Even carefully
designed interventions should not be assumed to bring
benefit and the potential for such interventions to do more
harm than good needs to be taken seriously, they
conclude.

Contact:

John Imrie, Senior Research Fellow, Department of
Sexually Transmitted Diseases, Royal Free and University
College Medical School, London, UK
Email: jimrie{at}gum.ucl.ac.uk
 


FOR ACCREDITED JOURNALISTS

Embargoed press releases and articles are available from:

Public Affairs Division
BMA House
Tavistock Square
London WC1H 9JR
(contact: pressoffice{at}bma.org.uk)
 
and from:

the EurekAlert website, run by the American Association for the
Advancement of Science
(http://www.eurekalert.org)
 




Access jobs at BMJ Careers
Whats new online at Student 

BMJ